Lumida
/NGNE
⌘K
Neurogene Inc

Neurogene Inc

NGNE
$35.48USD-1.77%-0.64 today

MARKET CAP

710.0M

P/E (TTM)

FWD P/E

DAY RANGE

$35 – $38

52W RANGE

$16
$44

AI Summary

Stalk
Buy NowMedium

The stock maintains a bullish medium- and long-term structure, anchored by rising major moving averages and a sequence of higher lows. A recent pullback into the 9/21 EMA support zone was absorbed, signaling acceptance and a favorable entry bias. RSI holds in neutral territory, avoiding overbought extremes. Execution is recommended now, buying into minor pullbacks toward the EMA support area.

  • Phase 1/2 NGN-401 trial saw 100% participants improving, averaging 4.7 milestones
  • Analysts’ average $83.67 target implies ~135% potential upside
  • Q2 net loss of $34.5M (-$1.53/share) underscores cash burn
Full analysis →
Insider Trades13 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jul 6, 2026SellNGNEChristine Mikail CvijicPresident and CFO4,800$36.12$710.0M-18.74%+122.72%$173.4K-2.71%10b5-1Buy Now
Jul 1, 2026SellNGNEChristine Mikail CvijicPresident and CFO4,800$34.71$710.0M-18.74%+122.72%$166.6K-1.73%10b5-1Buy Now
May 6, 2026SellNGNEChristine Mikail CvijicPresident and CFO9,600$31.25$710.0M-18.74%+122.72%$300.0K-4.76%10b5-1Buy Now
Mar 26, 2026SellNGNEJulie JordanChief Medical Officer828$21.89$710.0M-18.74%+122.72%$18.1K-6.23%Buy Now
Mar 26, 2026SellNGNEChristine Mikail CvijicPresident and CFO2,558$21.62$710.0M-18.74%+122.72%$55.3K-2.42%Buy Now
Mar 26, 2026SellNGNERachel McminnChief Executive Officer3,352$22.07$710.0M-18.74%+122.72%$74.0K-0.25%Buy Now
Mar 13, 2026SellNGNEChristine Mikail CvijicPresident and CFO4,045$20.81$710.0M-18.74%+122.72%$84.2K-1.25%Buy Now
Mar 13, 2026SellNGNEStuart CobbChief Scientific Officer6,797$20.81$710.0M-18.74%+122.72%$141.4K-6.71%10b5-1Buy Now
Feb 27, 2026SellNGNEChristine Mikail CvijicPresident and CFO4,800$25.11$710.0M-18.74%+122.72%$120.5K-4.19%10b5-1Buy Now
May 14, 2025SellNGNEStuart CobbChief Scientific Officer6,797$15.15$710.0M-18.74%+122.72%$103.0K-24.63%10b5-1Buy Now
Mar 13, 2025SellNGNEChristine Mikail CvijicPresident and CFO4,501$16.94$710.0M-18.74%+122.72%$76.2K-5.86%Buy Now
Nov 22, 2024BuyNGNEChristine Mikail CvijicPresident and CFO24,000$20.48$710.0M-18.74%+122.72%$491.4K+45.42%Buy Now
Nov 22, 2024BuyNGNERachel McminnChief Executive Officer47,500$20.40$710.0M-18.74%+122.72%$969.0K+3.80%Buy Now